LPGO — Lipigon Pharmaceuticals AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Lipigon Pharmaceuticals AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	SAS	SAS	SAS	SAS	—
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	12.6	28.5	9.64	31.9	11.8
Net Total Accounts Receivable
Net Total Receivables	1.03	0.589	0.969	1.25	2.05
Prepaid Expenses
Total Other Current Assets
Total Current Assets	15.2	29.3	10.7	33.6	14.6
Other Long Term Assets
Total Assets	15.2	29.4	10.8	33.6	14.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.26	6.47	6.95	5.16	7.06
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.26	6.47	6.95	5.16	7.06
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	13	23	3.87	28.4	7.76
Total Liabilities & Shareholders' Equity	15.2	29.4	10.8	33.6	14.8
Total Common Shares Outstanding